Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/WA/Kennewick

Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kennewick, WA

Studies commonly pay $75 to $4,500 per completed study

54 clinical trials are currently recruiting participants within 30 miles of Kennewick. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

54studies recruiting

4+research centers nearby

3condition categories

Live from the NIH registry

Studies recruiting near Kennewick right now

Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Endometrial Cancer, Malignant Solid Tumour Phase 3 Interventional 800 participants sought

Research Site — Kennewick, Washington (2.0 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT07044336)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

FAmily Engagement Strategy for Coordinated Specialty Care

Family Members, Implementation N/A Interventional 900 participants sought

Comprehensive Healthcare — Pasco, Washington (4.5 mi) · Sponsor: Washington State University

See eligibility & contact on ClinicalTrials.gov (NCT06945055)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07091617)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma Phase 2 Interventional 152 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04858334)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Phase 2 Interventional 26 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05647265)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Canadian Cancer Trials Group

See eligibility & contact on ClinicalTrials.gov (NCT06592924)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Malignant Solid Neoplasm N/A Interventional 760 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT06295367)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06580314)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma Phase 3 Interventional 294 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Eastern Cooperative Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT06724237)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Breast Cancer Phase 3 Interventional 420 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT05646862)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT03866382)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03418961)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Early Breast Cancer Phase 3 Interventional 1,400 participants sought

Kadlec Clinic Hematology and Onco — Kennewick, Washington (2.0 mi) · Sponsor: Novartis Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05827081)

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Hodgkin Lymphoma, Non-Hodgkin Lymphoma N/A Observational 2,000 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT06002828)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Wake Forest University Health Sciences

See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05561387)

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer Phase 3 Interventional 230 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT05894239)

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Central Line Associated Blood Stream Infections (CLABSI) N/A Interventional 17,800 participants sought

Kadlec Regional Medical Center — Richland, Washington (8.1 mi) · Sponsor: Swedish Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT07108660)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 3 Interventional 804 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04423211)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought

Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Actively enrolling

Studies you may be able to join near Kennewick

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Kennewick

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Kadlec Clinic - Hematology and Oncology

★ 4.3

7360 W Deschutes Ave, Kennewick, WA 99336

(509) 942-2540

Website

"My Dr is from Pakistan she is very brilliant and positive with patients very nice she is the future of this hospital we are really happy with her."

— Ron Patel, 5★

Tri-Cities Research District

3250 Port of Benton Blvd, Richland, WA 99354

(509) 375-0360

Website

Kadlec Clinic - Rheumatology

★ 3.5

6710 W Okanogan Pl, Kennewick, WA 99336

(509) 942-2528

Website

"I've only been here once after being on a 9 month waiting list.. I've seeing several Rheumatologest without finding one who could help me over ten ye…"

— D E W Adventures, 4★

Kadlec Neuroscience Center

★ 2.8

1100 Goethals Dr, Richland, WA 99352

Website

"Dr. Spencer is different. He is a refreshing reminder that not all providers should be cold and clinical. He maintained being professional and was ve…"

— Vlad III, 5★

Clinical trials in Kennewick: what's recruiting

The Kennewick area currently has 54 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kennewick, the most active research areas are:

Cancer & Oncology20 studies
Liver & Kidney1 studies
Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Kennewick, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kennewick

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kennewick participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Kennewick?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Kennewick?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

How often do new paid studies open in Kennewick?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Kennewick.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kennewick typically complete one or two studies per year.

Paid clinical trials near Kennewick

Other metros within reach

Spokane, WA294 Bellevue, WA1,509 Tacoma, WA1,453 Seattle, WA1,501 Vancouver, WA1,020 Marysville, WA198 Portland, OR1,020 Nampa, ID253

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kennewick Bladder Issues Due To Spinal Cord Injury in Kennewick All conditions

More of WA

Bellevue1,509 Seattle1,501 Bremerton1,475 Tacoma1,453 Vancouver1,020 Spokane294 Olympia226 Marysville198

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts